Japanese
English
- 販売していません
- Abstract 文献概要
- 1ページ目 Look Inside
- 参考文献 Reference
【目的】脳卒中患者の上肢機能評価の臨床的に意義のある最小変化量(MCID)を統合し質を評価すること.【方法】Fugl-Meyer assessment(FMA),Action Research Arm Test(ARAT),Motor Activity Log(MAL)のMCIDを算出した研究を複数の検索データベースから抽出した.【結果】FMAが4編(4.0〜12.4点),ARATが1編(12〜17点),MALが1編(1.0〜1.1点)であり,脳卒中発症からの時期や介入内容などが異なっていた.【結論】脳卒中上肢機能評価のMCID値を参照する際には各研究の対象者や介入条件を考慮する必要がある.
To investigate and summarize the minimum clinically important difference (MCID) in the assessment of upper limb function after stroke. [Methods] Studies that calculated the MCID using the Fugl-Meyer Assessment (FMA), the Action Research Arm Test (ARAT), and the Motor Activity Log (MAL) were extracted from multiple search databases. [Results] Four FMA (4.0-12.4 points), one ARAT (12-17 points), and one MAL (1.0-1.1 points) studies were included, all of which differed in terms of time since stroke onset and intervention details. [Conclusion] It is necessary to consider the subjects and intervention conditions of each study when referring to MCID values for the assessment of upper limb function after stroke.
Copyright © 2023, Japanese Association of Occupational Therapists. All rights reserved.